↓ Skip to main content

Dove Medical Press

Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis

Overview of attention for article published in Drug Design, Development and Therapy, May 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
95 Mendeley
Title
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Published in
Drug Design, Development and Therapy, May 2019
DOI 10.2147/dddt.s162913
Pubmed ID
Authors

Veena Mathew, Annabel K Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 19%
Researcher 12 13%
Student > Bachelor 9 9%
Student > Postgraduate 5 5%
Professor > Associate Professor 5 5%
Other 12 13%
Unknown 34 36%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 17 18%
Medicine and Dentistry 14 15%
Biochemistry, Genetics and Molecular Biology 11 12%
Chemistry 9 9%
Neuroscience 3 3%
Other 7 7%
Unknown 34 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2021.
All research outputs
#8,538,940
of 25,385,509 outputs
Outputs from Drug Design, Development and Therapy
#641
of 2,268 outputs
Outputs of similar age
#147,670
of 363,254 outputs
Outputs of similar age from Drug Design, Development and Therapy
#7
of 31 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,254 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.